PARP1 and cancer: It improves our understanding of how high Wnt signaling maintains stemness, provides options for the treatment of Wnt high cancers by a combination of Wnt inhibitors with PARP inhibitors, and suggests options for overcoming resistance to radiation and chemotherapies by inhibiting Wnt signaling.